HLB Therapeutics Co.,Ltd.
115450
Classement en actions
#18248
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Prix de l'action
$2.02
Capitalisation boursière
$190.66M
Changement (1 jour)
7.96%
Changement (1 an)
-1.16%
Pays
KR
Échange HLB Therapeutics Co.,Ltd. (115450)
Catégorie
Healthcare
Historique du prix de l'action pour HLB Therapeutics Co.,Ltd. (115450)
Prix de clôture le plus élevé : $1.94 le 2026-10-01
Prix de clôture le plus bas : $9.82 le 2010-03-01
Prix de clôture le plus bas : $9.82 le 2010-03-01
Historique du prix de l'action de HLB Therapeutics Co.,Ltd. de 2010 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -4.53% |
| 2025 | -69.48% |
| 2024 | 142.67% |
| 2023 | -24.36% |
| 2022 | -34.28% |
| 2021 | -50.71% |
| 2020 | 1.61% |
| 2019 | 7.70% |
| 2018 | -17.13% |
| 2017 | 106.04% |
| 2016 | 24.88% |
| 2015 | 254.54% |
| 2014 | 20.37% |
| 2013 | -14.85% |
| 2012 | -28.46% |
| 2011 | -62.15% |
| 2010 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
